Wntß-Catenin : A New Therapeutic Approach to Acute Myeloid Leukemia

الملخص EN

Recent studies have shown genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway, thus influencing the initiation and progression of acute myeloid leukemia (AML).

Of major importance, these findings may lead to novel treatment strategies exploiting targeted modulation of Wnt signaling.

This paper comprises the latest status of knowledge concerning the role of Wnt pathway alteration in AML and outlines future lines of research and their clinical perspectives.